Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

ClinicalTrials.gov ID: NCT01907854

Public ClinicalTrials.gov record NCT01907854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, Europe and North America. The aim of the trial is to investigate the efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes not achieving adequate glycaemic control on sitagliptin and metformin.

Study identification

NCT ID
NCT01907854
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
407 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2013 (Actual)
Primary completion
Jun 15, 2015 (Actual)
Completion
Jun 15, 2015 (Actual)
Last update posted
Oct 2, 2018

2013 – 2015

United States locations

U.S. sites
58
U.S. states
26
U.S. cities
49
Facility City State ZIP Site status
Novo Nordisk Investigational Site Phoenix Arizona 85018 —
Novo Nordisk Investigational Site Phoenix Arizona 85027 —
Novo Nordisk Investigational Site Tucson Arizona 85704 —
Novo Nordisk Investigational Site Tucson Arizona 85724 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Mission Viejo California 92691 —
Novo Nordisk Investigational Site Roseville California 95661 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80909 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80922 —
Novo Nordisk Investigational Site Chiefland Florida 32626 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33308 —
Novo Nordisk Investigational Site Hialeah Florida 33012 —
Novo Nordisk Investigational Site Jacksonville Florida 32207 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Jacksonville Florida 32258 —
Novo Nordisk Investigational Site Miami Florida 33183 —
Novo Nordisk Investigational Site North Miami Florida 33181 —
Novo Nordisk Investigational Site Port Charlotte Florida 33952 —
Novo Nordisk Investigational Site Johns Creek Georgia 30097 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Blackfoot Idaho 83221 —
Novo Nordisk Investigational Site Arlington Heights Illinois 60005-4144 —
Novo Nordisk Investigational Site Chicago Illinois 60604 —
Novo Nordisk Investigational Site Peoria Illinois 61602 —
Novo Nordisk Investigational Site Skokie Illinois 60077 —
Novo Nordisk Investigational Site Avon Indiana 46123 —
Novo Nordisk Investigational Site Evansville Indiana 47714 —
Novo Nordisk Investigational Site Evansville Indiana 47725 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site Bangor Maine 04401 —
Novo Nordisk Investigational Site Fall River Massachusetts 02720 —
Novo Nordisk Investigational Site Troy Michigan 48085-5524 —
Novo Nordisk Investigational Site City of Saint Peters Missouri 63376 —
Novo Nordisk Investigational Site Las Vegas Nevada 89119 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site Elizabeth New Jersey 07202 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site Charlotte North Carolina 28210 —
Novo Nordisk Investigational Site Salisbury North Carolina 28144 —
Novo Nordisk Investigational Site Akron Ohio 44311 —
Novo Nordisk Investigational Site Reading Pennsylvania 19606 —
Novo Nordisk Investigational Site Moncks Corner South Carolina 29461 —
Novo Nordisk Investigational Site Orangeburg South Carolina 29118 —
Novo Nordisk Investigational Site Memphis Tennessee 38119 —
Novo Nordisk Investigational Site Edinburg Texas 78539 —
Novo Nordisk Investigational Site Fort Worth Texas 76104 —
Novo Nordisk Investigational Site Houston Texas 77024 —
Novo Nordisk Investigational Site Houston Texas 77030 —
Novo Nordisk Investigational Site Houston Texas 77036 —
Novo Nordisk Investigational Site Houston Texas 77079 —
Novo Nordisk Investigational Site Midland Texas 79707 —
Novo Nordisk Investigational Site New Braunfels Texas 78130 —
Novo Nordisk Investigational Site North Richland Hills Texas 76180 —
Novo Nordisk Investigational Site San Antonio Texas 78245 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Virginia Beach Virginia 23454 —
Novo Nordisk Investigational Site Spokane Washington 99202-3649 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01907854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2018 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01907854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →